# Integra Therapeutics SL

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/integra-therapeutics-sl

- Industry: Biotechnology
- Headquarters: Barcelona, Spain
- Website: www.integra-tx.com
- Total disclosed funding: $6.8M
- Latest round: Seed (Mar 29, 2022)
- Investors on record: 4

## About

Based in Barcelona, Spain, and founded in 2020, Integra Therapeutics SL is a biotechnology company. Avencia Sánchez-Mejías (CEO) and Marc Güell are the co-founders of the company. The company is a spin-off from Pompeu Fabra University (UPF) in Barcelona, based on technology developed in the Translational Synthetic Biology Lab. In December 2021, Integra Therapeutics SL raised EUR 4.5 million in seed funding from new investor Advent France Biotechnology, Invivo Capital Partners, and Takeda Ventures. In September 2025, Integra Therapeutics SL raised EUR 10.7 million in pre-series A funding from new investor Centre for the Development of Industrial Technology, with participation from returning investors AdBio Partners, Columbus Venture Partners, European Innovation Council, Invivo Partners, and Takeda Ventures.

The company develops next-generation gene-writing tools to boost the efficiency and safety of advanced therapies. Integra is developing a novel gene writing technology that can resolve some of the main technical limitations of gene therapy as it can be used to paste DNA sequences of any size gene with high precision.

The company plans to use the funding received in September 2025 to improve its gene tools, test new cancer treatments, and work on a medicine for a rare liver disease in kids.

## Funding rounds

- Seed, Mar 29, 2022, $1.7M — Columbus Venture Partners
- Seed, Dec 2, 2021, $5.1M — Takeda Ventures, AdBio Partners, Invivo Partners

## Investors

- Takeda Ventures (https://capitalatlas.ai/funds/takeda-ventures) — Seed
- AdBio Partners (https://capitalatlas.ai/funds/adbio-partners) — Seed
- Invivo Partners (https://capitalatlas.ai/funds/invivo-partners) — Seed
- Columbus Venture Partners (https://capitalatlas.ai/funds/columbus-venture-partners) — Seed